BioCentury | Oct 15, 2020
Product Development
Oct. 14 Quick Takes: FDA approves first Ebola therapy; plus Vertex tumbles after hours on AAT discontinuation
...Interleukin-1 receptor-like 2
BC Staff
VX-814
VX-864
Guadecitabine (SGI-110, s110)
Makena (gestiva, hydroxyprogesterone caproate injection, 17P)
Regeneron Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Otsuka
Codiak BioSciences
Ori Biotech Ltd.
Simcere...
